Company registration number 11080888 (England and Wales)
BELMONT HEALTHCARE (HASLINGTON) LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
BELMONT HEALTHCARE (HASLINGTON) LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 6
BELMONT HEALTHCARE (HASLINGTON) LIMITED
BALANCE SHEET
AS AT 31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
4,568,650
4,240,887
Current assets
Debtors
5
200,809
297,930
Cash at bank and in hand
83,715
8,153
284,524
306,083
Creditors: amounts falling due within one year
6
(1,074,934)
(1,757,590)
Net current liabilities
(790,410)
(1,451,507)
Total assets less current liabilities
3,778,240
2,789,380
Creditors: amounts falling due after more than one year
7
(71,246)
(88,403)
Provisions for liabilities
(211,659)
(211,659)
Net assets
3,495,335
2,489,318
Capital and reserves
Called up share capital
100
100
Revaluation reserve
2,059,870
1,687,870
Profit and loss reserves
1,435,365
801,348
Total equity
3,495,335
2,489,318

The notes on pages 2 to 6 form part of these financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 9 December 2025
A H Hutchison
Director
Company registration number 11080888 (England and Wales)
BELMONT HEALTHCARE (HASLINGTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 2 -
1
Accounting policies
Company information

Belmont Healthcare (Haslington) Limited is a private company limited by shares incorporated in England and Wales. The registered office is Belmont Healthcare, Suite 3, Croft House, Black Soils Road, Redditch, B98 9HN. The principal place of business is Haslington Lodge Care Home, Bean Road, Greenhithe, Kent, DA9 9JB.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

 

 

The financial statements of the company are consolidated in the financial statements of Belmont Healthcare Management Limited. These consolidated financial statements are available from its registered office Suite 3, Croft House, Black Soils Road, Redditch, B98 9HN.

1.2
Turnover

Revenue comprises sales of goods or services provided to customers net of other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

 

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

These financial statements for the year ended 31 March 2025 are the first financial statements of Belmont Healthcare (Haslington) Limited prepared in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland. The date of transition to FRS 102 was 1 April 2024. The reported financial position and financial performance for the previous period are not affected by the transition to FRS 102.

BELMONT HEALTHCARE (HASLINGTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 3 -

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recoverable.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold land and buildings
No depreciation
Fixtures and fittings
10% straight line
Motor vehicles
10% straight line
Property improvemnets
10% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.5
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.6
Leases
As lessee

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

1.7

Debtors and creditors receivable/payable within one year

Debtors and creditors with no stated interest rate and receivable and payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

1.8

Loans and borrowings

Loans and borrowings are initially recognised at the transaction price including transaction costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment. If an arrangement constitutes a financing transaction it is measured at present value.

BELMONT HEALTHCARE (HASLINGTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 4 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
55
52
4
Tangible fixed assets
Freehold land and buildings
Fixtures and fittings
Motor vehicles
Property improvemnets
Total
£
£
£
£
£
Cost
At 1 April 2024
3,250,000
897,740
122,718
267,839
4,538,297
Additions
-
0
35,670
-
0
20,911
56,581
Revaluation
372,000
-
0
-
0
-
0
372,000
At 31 March 2025
3,622,000
933,410
122,718
288,750
4,966,878
Depreciation and impairment
At 1 April 2024
-
0
225,201
12,272
59,937
297,410
Depreciation charged in the year
-
0
60,364
12,272
28,182
100,818
At 31 March 2025
-
0
285,565
24,544
88,119
398,228
Carrying amount
At 31 March 2025
3,622,000
647,845
98,174
200,631
4,568,650
At 31 March 2024
3,250,000
672,539
110,446
207,902
4,240,887
BELMONT HEALTHCARE (HASLINGTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 5 -
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
6,537
86,053
Amounts owed by group undertakings
155,797
195,489
Other debtors
38,475
16,388
200,809
297,930
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
38,072
41,956
Amounts owed to group undertakings
940,438
1,624,938
Taxation and social security
21,829
20,072
Other creditors
74,595
70,624
1,074,934
1,757,590
7
Creditors: amounts falling due after more than one year
2025
2024
£
£
Other creditors
71,246
88,403
8
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.

The auditor's report is unqualified and includes the following:

Opinion

In our opinion the financial statements:

Senior Statutory Auditor:
B D Eley FCA
Statutory Auditor:
Barnett Ravenscroft Limited
Date of audit report:
9 December 2025
BELMONT HEALTHCARE (HASLINGTON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 6 -
9
Parent company

The company is a wholly owed subsidiary of Belmont Healthcare Management Limited a company registered in England and Wales its registered address is Suite 3 Croft House, Black Soils Road, Redditch, B98 9HNMr A N Hutchison, is the sole director and shareholder of Belmont Healthcare Management Limited.

2025-03-312024-04-01falsefalsefalse09 December 2025CCH SoftwareCCH Accounts Production 2025.100No description of principal activityA H Hutchison110808882024-04-012025-03-31110808882025-03-31110808882024-03-3111080888core:LandBuildingscore:OwnedOrFreeholdAssets2025-03-3111080888core:FurnitureFittings2025-03-3111080888core:MotorVehicles2025-03-3111080888core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2025-03-3111080888core:LandBuildingscore:OwnedOrFreeholdAssets2024-03-3111080888core:FurnitureFittings2024-03-3111080888core:MotorVehicles2024-03-3111080888core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2024-03-3111080888core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-3111080888core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3111080888core:ShareCapital2025-03-3111080888core:ShareCapital2024-03-3111080888core:RevaluationReserve2025-03-3111080888core:RevaluationReserve2024-03-3111080888core:RetainedEarningsAccumulatedLosses2025-03-3111080888core:RetainedEarningsAccumulatedLosses2024-03-3111080888bus:Director12024-04-012025-03-3111080888core:LandBuildingscore:OwnedOrFreeholdAssets2024-04-012025-03-3111080888core:FurnitureFittings2024-04-012025-03-3111080888core:MotorVehicles2024-04-012025-03-3111080888core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2024-04-012025-03-31110808882023-04-012024-03-3111080888core:LandBuildingscore:OwnedOrFreeholdAssets2024-03-3111080888core:FurnitureFittings2024-03-3111080888core:MotorVehicles2024-03-3111080888core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2024-03-31110808882024-03-3111080888core:CurrentFinancialInstruments2025-03-3111080888core:CurrentFinancialInstruments2024-03-3111080888core:WithinOneYear2025-03-3111080888core:WithinOneYear2024-03-3111080888core:Non-currentFinancialInstruments2025-03-3111080888core:Non-currentFinancialInstruments2024-03-3111080888bus:PrivateLimitedCompanyLtd2024-04-012025-03-3111080888bus:FRS1022024-04-012025-03-3111080888bus:Audited2024-04-012025-03-3111080888bus:SmallCompaniesRegimeForAccounts2024-04-012025-03-3111080888bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP